Publications Database

Bent S. et al. (2012)

Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial.

Journal of Autism and Developmental Disorders

42(6), pp. 1127-1132.

Read Abstract (New Window)

Bent S. , Hendren. R. L. (2010)

Improving the prediction of response to therapy in autism.

Neurotherapeutics

7(3), pp. 232-240

Read Abstract (New Window)

Bent S. et al. (2014)

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.

Journal of the American Academy of Child and Adolescent Psychiatry

June, 53(6), pp. 658-666.

Read Abstract (New Window)

Bent S. , Bertoglio K. , Hendren. R. L. (2009)

Omega-3 fatty acids for autistic spectrum disorder: A systematic review.

Journal of Autism and Developmental Disorders

39(8), pp. 1145-1154

Read Abstract (New Window) Read Full (New Window)

Bent S. , Bertoglio K. , Hendren. R. L. (2009)

Regarding omega-3 fatty acids in severe autism.

Archives of Medical Research

40(1), pp. 64

Bertoglio K. et al. (2010)

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism.

Journal of Alternative and Complementary Medicine

May, 16(5), pp. 555-560

Read Abstract (New Window)

Blaucok-Busch E. et al. (2012)

Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder.

Maedica (Buchar)

7(3), pp. 214-221.

Read Abstract (New Window) Read Full (New Window)

Bolman W. M. , Richmond J. (1999)

A double-blind, placebo-controlled crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.

Journal of Autism and Developmental Disorders

29(3), pp. 191-194

Read Abstract (New Window)

Boris M. , Goldblatt A. , Edelson S. M. (2006)

Improvement in children with autism treated with intravenous gamma globulin.

Journal of Nutritional and Environmental Medicine

15(4), 169-176

Read Abstract (New Window) Read Full (New Window)

Bradstreet J. J. et al. (2003)

A case-control study of mercury burden in children with autistic spectrum disorders.

Journal of American Physicians and Surgeons

8(3), pp. 76-79

Read Full (New Window)

Bradstreet J. J. et al. (2014)

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Cell Transplantation

S105-12.

Read Abstract (New Window)

Bradstreet J. J. , Vogelaar E. , Thyer L. (2014)

Initial observations of elevated alpha-n-acetylgalactosaminidase activity associated with autism and observed reductions from gc protein: Macrophage activating factor injections.

Autism Insights

Read Abstract (New Window) Read Full (New Window)

Brent J. (2013)

Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.

Journal of Medical Toxicology

9(4), pp. 370-372.

Read Abstract (New Window)

British Dietetic Association (2016)

Vitamin D.

London:

Read Full (New Window)

Brondino N. et al. (2015)

Complementary and alternative therapies for autism spectrum disorder.

Evidence Based Complementary and Alternative Medicine

Read Abstract (New Window) Read Full (New Window)

Brown M. J. et al. (2006)

Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005.

Pediatrics

118(2), e534-536

Read Full (New Window)

Brudnak M. A. (2001)

Application of genomeceuticals to the molecular and immunological aspects of autism.

Medical Hypotheses

57(2), pp. 186-191

Read Abstract (New Window)

Brudnak M. A. et al. (2002)

Enzyme-based therapy for autism spectrum disorders: is it worth another look?

Medical Hypotheses

58(5), pp. 422-428

Read Abstract (New Window)

Brudnak M. A. (2002)

Probiotics as an adjuvant to detoxification protocols.

Medical Hypotheses

58(5), pp. 382-385

Read Abstract (New Window)

Buie T. (2013)

The relationship of autism and gluten.

Clinical Therapeutics

May, 35(5), pp. 578-583.

Read Abstract (New Window)